UK Government Declares Investment to Revolutionized Utilization of AI in Life Science & Healthcare, Aids “AI in Precision Medicine Market” to Surpass USD 14.5 Billion by 2030

Written by MarkNtel Advisors  »  Updated on: October 24th, 2024

A recently published analytical report description by Markntel Advisors describes the significant growth drivers that facilitate boosting market growth. Such as the involvement of government and regulated bodies of widespread countries like the UK, India, Germany, and others towards the adoption of Artificial intelligence in precision medicine. This supports the development of novel precision medicine treatments for diseases like cancer, dementia, etc. The report further elaborates on the growth parameters using a supportive instance: recently in 2023, the UK government stated an investment of approx.  USD 132 million to accelerate the utilization of AI in life science and healthcare including in the development of novel precision medicine treatments. This initiative aids the exponential industry expansion with lucrative growth aspects.

Advantages and Disadvantages of Utilization of AI in Precision Medicine:

Advantages:

  • Facilitates real Time Data,
  • Streamlines tasks,
  • Save Time and Resources,
  • Assists Research,
  • Chances of Reducing Physical Stress.

Disadvantages:

  • Needs Human Surveillance
  • May Overlook Social Variables
  • Inaccuracies are Still Possible
  • Susceptible to Security Risks,

Artificial Intelligence (AI) in Precision Medicine Market Analysis: Reveals Further Growth

The report comprises “Global Artificial Intelligence (AI) in Precision Medicine Market Research Report: Global Artificial Intelligence (AI) in Precision Medicine Industry Bifurcations - By Component (Hardware, Software, Services), By Technology (Deep Learning, Machine Learning, Querying Method, Natural Language Processing, Context-Aware Processing), By Therapeutic Application (Oncology, Neurosciences, Cardiology, Hematological Diseases, Autoimmune Diseases, Others (Respiratory, Kidney Diseases, etc.), By region (North America, South America, Europe, The Middle East & Africa, and Asia-Pacific) Forecast (2024-2030)”, According to the report, the Global Artificial Intelligence (AI) in Precision Medicine Market size was valued at USD 1.7 billion in 2023 and is projected to reach USD 14.5 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 27% during the forecast period, i.e., 2024-30. The market growth is also driven by the rising genomic research projects with considerable funding from government and private research bodies.

Something New about Growing Market

The rising prevalence of cancer cases propels the demand for the integration of AI in precision medicine. Cancer is a disease that requires therapies specifically according to the patient’s characteristics, somehow the available treatments like chemotherapy, radiation therapy, and others have not been very effective. This is the reason conventional treatments have to be replaced with modern technologies which not only eliminate side effects but are also available at minimal cost.

Conclusion

The blog comprises Global market players in the Artificial Intelligence (AI) in Precision Medicine industry, with market product information. This blog entails details regarding the prominent factors behind the surging demand for futuristic growth and new opportunities that facilitate market development. Market players such as Tempus, Intel Corporation, Zephyr AI, IBM, NVIDIA Corporation, Intuz, Google LLC, Persistent Systems, Owkin, Inc., and Others, including other leading companies, facilitate revolutionizing the global market and promoting a secure future for the Artificial Intelligence (AI) in Precision Medicine market.

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.


Disclaimer:

We do not claim ownership of any content, links or images featured on this post unless explicitly stated. If you believe any content or images infringes on your copyright, please contact us immediately for removal ([email protected]). Please note that content published under our account may be sponsored or contributed by guest authors. We assume no responsibility for the accuracy or originality of such content. We hold no responsibilty of content and images published as ours is a publishers platform. Mail us for any query and we will remove that content/image immediately.